2022年12月20日

新闻分享这篇文章分享这篇文章提供的公司看作是一个创新的领导人在虚拟以现实为基础的沉浸式疗法促进文化的多样性,股本,洛杉矶和归属感,12月20日,2022 / AppliedVR从一个身临其境疗法推进先锋小说的医学方法,宣布赢得了四个奖项的优秀企业文化,支持员工,今年第二次获得同等。同等奖项来自情绪评级匿名提供的员工对他们的工作场所在12个月期间在多个类别。从1500万年评级在70000年公司选择赢家。100家公司在每个类别,AppliedVR排名# 26最佳公司文化,# 32最佳CEO, # 70最佳公司对于女性来说,在最好的公司和# 57多样性对小中型公司。之前,2022年10月,应用VR拿回家相对奖最快乐的员工,最好的补偿,最佳工作与生活的平衡,和最佳的津贴和福利。“我们成立AppliedVR作为一个以人为本的组织。我们设定和实现雄心勃勃的劳动力多样性的目标,因为我们知道多样化,授权团队提供更清晰的见解和新的视角,使我们能够更好地为我们的病人和驱动改进业务的结果。AppliedVR也展示了明确承诺股本和归属感,我鼓舞,这些行为是反映在我们的团队成员的经验,”马修Stoudt AppliedVR联合创始人兼首席执行官说。“我们的团队成员使AppliedVR极其愉快和欢迎的地方。“AppliedVR医学正在引领一个新的类别通过虚拟地址各种迹象以现实为基础的疗法。 The company's flagship product, the RelieVRx TM system, recently became the first immersive therapeutic to receive FDA authorization for treating pain – specifically as an adjunctive treatment for chronic lower back pain. AppliedVR is conducting ongoing research to support additional indications to help an ever-growing population of patients with intractable conditions who lack the care and access to the treatment they need. AppliedVR is growing quickly and hiring nationally across multiple teams. For more information, please visit the AppliedVR careers page . About AppliedVR AppliedVR is creating a new reality in healthcare. We are pioneering immersive therapeutics (ITx), a new category of medicine, to treat intractable health conditions that affect millions of people worldwide. Today, AppliedVR's treatments represent a robust approach to chronic lower back pain (CLBP) that empowers patients with an intuitive device they can self-manage at home. AppliedVR's RelieVRx™ program is the first VR-based, prescription therapeutic to receive Breakthrough Device Designation and De Novo authorization by the FDA for CLBP. AppliedVR's wellness programs have been trusted by more than 200 leading health systems and thousands of healthcare professionals globally, used on more than 60,000 patients. For more information, visit www.appliedvr.io . Press Contact